Clinical Trials | October 30, 2023
SN Bioscience announces Phase 1 study results of SN-38 nanoparticle anti-cancer drug
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Minister was briefed on the nationwide dengue situation
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Subscribe To Our Newsletter & Stay Updated
